Related Experiment Video
Updated: Aug 9, 2026

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications
1Department of Urology and Biochemistry, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA. lwchung@emory.edu
Cancer
|January 28, 2003
Summary
Prostate cancer bone metastasis involves complex tumor-bone interactions. Targeting both tumor cells and bone stroma shows promise for improving patient outcomes in advanced prostate carcinoma bone disease.
Area of Science:
- Oncology
- Cell Biology
- Biomedical Research
Background:
- Prostate carcinoma bone metastasis is a complex, multistep process.
- Tumor cell interaction with the bone microenvironment is crucial.
- This study reviews implications of bone metastasis in prostate cancer.
Purpose of the Study:
- To investigate the interaction between prostate carcinoma cells and bone stroma.
- To explore the biologic and therapeutic implications of bone metastasis.
- To introduce a cotargeting strategy for prostate carcinoma bone metastasis.
Main Methods:
- Established tumor models for studying prostate carcinoma and bone stroma interactions (2D and 3D).
- Coculture experiments demonstrated enhanced prostate carcinoma cell growth and survival.
- Introduced a cotargeting concept for treatment.
Main Results:
- Observed genotypical and phenotypical responses in tumor epithelium cocultured in 3D.
- Identified a 'vicious cycle' of tumor-bone interactions mediated by secreted molecules.
- Cotargeting strategies showed promising results in preclinical models and clinical trials.
Conclusions:
- Understanding tumor-bone stroma interactions is key to improving prostate carcinoma bone metastasis.
- Targeting these interactions can reduce patient suffering and improve survival.
- Advanced bone metastasis in prostate carcinoma may be better managed through targeted therapies.

